Emvena Therapeutics secures investment from the Penn-BioNTech Innovative Therapeutics Seed Fund. The funding will advance its mRNA medicines targeting maternal and fetal conditions.
Round Type
Seed
PhiladelphiaBiotechnologyHealth CareTherapeuticsInvestors
Description
Emvena Therapeutics, based in Philadelphia, received an investment to support its biotechnology efforts. The funds will be used for investigational new drug-enabling studies and to expand their platform. The specific amount of the deal was not disclosed. Founded in 2026, the company focuses on mRNA medicines targeting serious conditions in mothers and fetuses.
Who to call at Emvena Therapeutics, and when
A new round usually means Emvena Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Emvena Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Emvena Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Emvena Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Emvena Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Emvena Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.